Long-Term Survival of Patients With Chemotherapy-Naïve Metastatic Nasopharyngeal Carcinoma Receiving Cetuximab Plus Docetaxel and Cisplatin Regimen

Long-Term Survival of Patients With Chemotherapy-Naïve Metastatic Nasopharyngeal Carcinoma Receiving Cetuximab Plus Docetaxel and Cisplatin Regimen

Purpose: Metastatic nasopharyngeal carcinoma (mNPC) remains incurable. This prospective study aimed to investigate whether adding cetuximab to cisplatin-based induction therapy could improve efficacy and survival for chemotherapy-naïve mNPC patients.Patients and Methods: Eligible chemotherapy-naïve...

Full description

Bibliographic Details
Main Authors: Mengping Zhang, He Huang, Xueying Li, Ying Huang, Chunyan Chen, Xiaojie Fang, Zhao Wang, Chengcheng Guo, Sioteng Lam, Xiaohong Fu, Huangming Hong, Ying Tian, Taixiang Lu, Tongyu Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Oncology
Subjects:
survival
chemotherapy
metastatic nasopharyngeal carcinoma
cetuximab
induction therapy
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01011/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01011/full

Similar Items